New insider activity at Encompass Health ( (EHC) ) has taken place on February 14, 2025.
Chief Administrative Officer Andrew Price recently executed a significant financial move by selling 5,042 shares of Encompass Health stock. This transaction amounted to a total of $495,578, indicating a strategic decision in managing his investment portfolio.
Recent Updates on EHC stock
In the last 24 hours, Encompass Health has experienced positive developments, with both KeyBanc and Barclays raising their price targets due to impressive fourth-quarter results for 2024. KeyBanc highlighted the company’s strong performance, noting it as an attractive growth stock insulated from policy-related uncertainties. Barclays emphasized the company’s robust revenue and EBITDA guidance, which aligns with market expectations, reinforcing its strong operating momentum. Encompass Health reported a revenue increase of 12.7% and a 13.6% rise in adjusted EBITDA, driven by a 7.8% growth in discharges. The company issued 2025 guidance with optimistic projections for continued expansion and market leadership, despite facing challenges such as increased medical costs and uncertainties in provider tax benefits.
More about Encompass Health
YTD Price Performance: 6.35%
Average Trading Volume: 642,345
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $9.88B